These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31338966)

  • 1. Berberine attenuates XRCC1-mediated base excision repair and sensitizes breast cancer cells to the chemotherapeutic drugs.
    Gao X; Wang J; Li M; Wang J; Lv J; Zhang L; Sun C; Ji J; Yang W; Zhao Z; Mao W
    J Cell Mol Med; 2019 Oct; 23(10):6797-6804. PubMed ID: 31338966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptolide interferes with XRCC1/PARP1-mediated DNA repair and confers sensitization of triple-negative breast cancer cells to cisplatin.
    Zhang Z; Sun C; Zhang L; Chi X; Ji J; Gao X; Wang Y; Zhao Z; Liu L; Cao X; Yang Y; Mao W
    Biomed Pharmacother; 2019 Jan; 109():1541-1546. PubMed ID: 30551406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis.
    Zhao Y; Jing Z; Li Y; Mao W
    Oncol Rep; 2016 Jul; 36(1):567-72. PubMed ID: 27177238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma
    Ali R; Al-Kawaz A; Toss MS; Green AR; Miligy IM; Mesquita KA; Seedhouse C; Mirza S; Band V; Rakha EA; Madhusudan S
    Cancer Res; 2018 Dec; 78(24):6818-6827. PubMed ID: 30297533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine activates caspase-9/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo.
    Zhao Y; Jing Z; Lv J; Zhang Z; Lin J; Cao X; Zhao Z; Liu P; Mao W
    Biomed Pharmacother; 2017 Nov; 95():18-24. PubMed ID: 28826092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells.
    Liu L; Fan J; Ai G; Liu J; Luo N; Li C; Cheng Z
    Biol Res; 2019 Jul; 52(1):37. PubMed ID: 31319879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalin attenuates XRCC1-mediated DNA repair to enhance the sensitivity of lung cancer cells to cisplatin.
    Yin Z; Chen E; Cai X; Gong E; Li Y; Xu C; Ye Z; Cao Z; Pan J
    J Recept Signal Transduct Res; 2022 Jun; 42(3):215-224. PubMed ID: 33719846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property.
    Prasad CB; Prasad SB; Yadav SS; Pandey LK; Singh S; Pradhan S; Narayan G
    Sci Rep; 2017 Oct; 7(1):12876. PubMed ID: 28993682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines.
    Lin YS; Chiu YC; Tsai YH; Tsai YF; Wang JY; Tseng LM; Chiu JH
    J Cell Biochem; 2019 Aug; 120(8):13531-13544. PubMed ID: 30957305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer.
    Xu W; Wang S; Chen Q; Zhang Y; Ni P; Wu X; Zhang J; Qiang F; Li A; Røe OD; Xu S; Wang M; Zhang R; Zhou J
    Cell Death Dis; 2014 Feb; 5(2):e1055. PubMed ID: 24525731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2'-deoxycytidine lesions.
    Orta ML; Höglund A; Calderón-Montaño JM; Domínguez I; Burgos-Morón E; Visnes T; Pastor N; Ström C; López-lázaro M; Helleday T
    Nucleic Acids Res; 2014 Aug; 42(14):9108-20. PubMed ID: 25074383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine and Cisplatin Exhibit Synergistic Anticancer Effects on Osteosarcoma MG-63 Cells by Inhibiting the MAPK Pathway.
    Gao X; Zhang C; Wang Y; Zhang P; Zhang J; Hong T
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33802664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of berberine on p53 expression by TPA in breast cancer cells.
    Kim S; Han J; Kim NY; Lee SK; Cho DH; Choi MY; Kim JS; Kim JH; Choe JH; Nam SJ; Lee JE
    Oncol Rep; 2012 Jan; 27(1):210-5. PubMed ID: 21964832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro and in-vivo anti-breast cancer activity of synergistic effect of berberine and exercise through promoting the apoptosis and immunomodulatory effects.
    Ma W; Zhang Y; Yu M; Wang B; Xu S; Zhang J; Li X; Ye X
    Int Immunopharmacol; 2020 Oct; 87():106787. PubMed ID: 32707493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine sensitizes TRAIL-induced apoptosis through proteasome-mediated downregulation of c-FLIP and Mcl-1 proteins.
    Lee SJ; Noh HJ; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ
    Int J Oncol; 2011 Feb; 38(2):485-92. PubMed ID: 21170508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic screening for targets regulated by berberine in breast cancer cells.
    Wen CJ; Wu LX; Fu LJ; Yu J; Zhang YW; Zhang X; Zhou HH
    Asian Pac J Cancer Prev; 2013; 14(10):6089-94. PubMed ID: 24289631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plant Isoquinoline Alkaloid Berberine Exhibits Chromatin Remodeling by Modulation of Histone Deacetylase To Induce Growth Arrest and Apoptosis in the A549 Cell Line.
    Kalaiarasi A; Anusha C; Sankar R; Rajasekaran S; John Marshal J; Muthusamy K; Ravikumar V
    J Agric Food Chem; 2016 Dec; 64(50):9542-9550. PubMed ID: 27936791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STI571 sensitizes breast cancer cells to 5-fluorouracil, cisplatin and camptothecin in a cell type-specific manner.
    Sims JT; Ganguly S; Fiore LS; Holler CJ; Park ES; Plattner R
    Biochem Pharmacol; 2009 Aug; 78(3):249-60. PubMed ID: 19427998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enhancement of combination of berberine and metformin in inhibition of DNMT1 gene expression through interplay of SP1 and PDPK1.
    Zheng F; Wu J; Tang Q; Xiao Q; Wu W; Hann SS
    J Cell Mol Med; 2018 Jan; 22(1):600-612. PubMed ID: 28840963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth suppression of HER2-overexpressing breast cancer cells by berberine via modulation of the HER2/PI3K/Akt signaling pathway.
    Kuo HP; Chuang TC; Yeh MH; Hsu SC; Way TD; Chen PY; Wang SS; Chang YH; Kao MC; Liu JY
    J Agric Food Chem; 2011 Aug; 59(15):8216-24. PubMed ID: 21699261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.